EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Serum fatty acid profiles across clinicopathologic heterogeneity in breast cancer: an exploratory study

Patryk T Mucha iD, Agata Jedrzejewska, Alicja Pakiet, Patrycja Jablonska iD, Jacek Zielinski, Weronika Szczecinska, Miroslawa Puskulluoglu iD, Adriana Mika iD, Ewa M Slominska, Marta Tomczyk iD

Therapeutic Advances in Medical Oncology · 2026-05 · 18

DOI: 10.1177/17588359261436624 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Advances in Medical Oncology, online erschienen am 16.05.2026. Verfasst von Patryk T Mucha und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Medical University of Gdansk, Gdansk, Poland. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer (BC) is the most frequently diagnosed malignancy and the leading cause of cancer-related death in women. Beyond traditional clinical classifications, metabolic reprogramming has emerged as an additional layer of tumor heterogeneity. Fatty acids (FAs), essential for membrane synthesis, energy storage, and signaling, undergo dynamic remodeling in cancer and may reflect disease progression.

Objectives

To examine associations between serum FAs profiles and clinical-pathological features of BC, including tumor stage, surrogate subtype, lymph node status, and proliferative activity.

Design

A retrospective, cross-sectional study was conducted at a single institution to analyze metabolic signatures in patients with BC stratified by clinical and surrogate characteristics.

Methods

Serum FAs composition was analyzed by gas chromatography–mass spectrometry in 110 patients with BC before treatment initiation. Patients were categorized according to tumor stage, BC surrogate subtype, and Ki-67 proliferation index. Group comparisons and correlations were performed using standard parametric/non-parametric tests as appropriate, with Benjamini–Hochberg false discovery rate (FDR) correction across the FAs panel.

Results

In categorical comparisons (e.g., tumor stage, Ki-67, lymph node status), some FAs, particularly arachidonic acid (ARA), and selected saturated, branched-chain, and polyunsaturated species, were nominally elevated in more aggressive phenotypes, but none remained significant after FDR correction ( Q = 0.05). Correlation analysis using Ki-67 as a continuous variable revealed modest but consistent positive associations with multiple FAs. Notably, ARA, dihomo-γ-linolenic acid, docosapentaenoic acid, and several branched- and odd-chain species remained significantly correlated with Ki-67 after FDR adjustment.

Conclusion

This exploratory study suggests that specific serum FAs are modestly associated with tumor proliferative activity, supporting the concept that aggressive BC phenotypes may involve systemic lipid remodeling. Further prospective studies are needed to validate these findings and assess their potential clinical relevance.

Schlagwörter

Stichwörter der Autor:innen

arachidonic acidbreast cancerfatty acidsserum profilingsurrogate subtypes

Autor:innen und Institutionen

  • Department of Biochemistry, Medical University of Gdansk, Gdansk, Poland.
  • Department of Environmental Analysis, Faculty of Chemistry, University of Gdansk, Gdansk, Poland.
  • Department of Surgical Oncology, Medical University of Gdansk, Gdansk, Poland.
  • Department of Clinical Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Cracow, Poland.
  • Department of Pharmaceutical Biochemistry, Medical University of Gdansk, Gdansk, Poland.
  • Department of Biochemistry, Medical University of Gdansk, 80-210, Gdansk, Poland.

ORCID-Profile: Patryk T Mucha, Patrycja Jablonska, Miroslawa Puskulluoglu, Adriana Mika, Marta Tomczyk

Zitieren

APA

Mucha, P. T., Jedrzejewska, A., Pakiet, A., Jablonska, P., Zielinski, J., Szczecinska, W., Puskulluoglu, M., Mika, A., Slominska, E. M., & Tomczyk, M. (2026). Serum fatty acid profiles across clinicopathologic heterogeneity in breast cancer: an exploratory study. Therapeutic Advances in Medical Oncology, 18. https://doi.org/10.1177/17588359261436624

Vancouver

Mucha PT, Jedrzejewska A, Pakiet A, Jablonska P, Zielinski J, Szczecinska W, et al. Serum fatty acid profiles across clinicopathologic heterogeneity in breast cancer: an exploratory study. Therapeutic Advances in Medical Oncology. 2026;18. doi:10.1177/17588359261436624

BibTeX
@article{Mucha2026,
  author = {Mucha, Patryk T and Jedrzejewska, Agata and Pakiet, Alicja and Jablonska, Patrycja and Zielinski, Jacek and Szczecinska, Weronika and Puskulluoglu, Miroslawa and Mika, Adriana and Slominska, Ewa M and Tomczyk, Marta},
  title = {Serum fatty acid profiles across clinicopathologic heterogeneity in breast cancer: an exploratory study},
  journal = {Therapeutic Advances in Medical Oncology},
  year = {2026},
  volume = {18},
  doi = {10.1177/17588359261436624}
}
Kostenlos starten →